Parkinson's sleep study halted early: did safinamide help?
NCT ID NCT03968744
First seen Mar 16, 2026 · Last updated May 24, 2026 · Updated 4 times
Summary
This study looked at whether the drug safinamide could improve sleep quality in people with later-stage Parkinson's disease. Eleven participants took safinamide for 12 weeks, and researchers measured sleep using both questionnaires and overnight brain-wave recordings. The study was terminated early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDIOPATHIC PARKINSON'S DISEASE (AT LATER STAGE) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Neurocenter of Southern Switzerland - Ente Ospedaliero Cantonale (EOC)
Lugano, 6900, Switzerland
Conditions
Explore the condition pages connected to this study.